DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLinda M. Henricks, Jan H.M. Schellens, Geert-Jan Creemers et al.|The Lancet Oncology|2018Cited by 419
CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disordersClara D.M. van Karnebeek, André B. P. Kuilenburg, Maja Tarailo‐Graovac et al.|Genetics in Medicine|2024Cited by 13
Metachromatic LeukodystrophyMarije A B C Asbreuk, Nicole I. Wolf, Daphne H. Schoenmakers et al.|Neurology|2025Cited by 9